HIGHLIGHTS
- who: Caroline Gronnier and colleagues from the Department of Surgery, Magellan Center, Bordeaux University Hospital, Pessac, France have published the Article: Perioperative Cetuximab with Cisplatin and 5-Fluorouracil in Esogastric Adenocarcinoma: A Phase II Study, in the Journal: Cancers 2023, 15, 2188. of 19/02/2023
- what: The aim was combined evaluation of the tumor objective response (TOR) assessed by computed tomography and the absence of major toxicities resulting in discontinuation of neoadjuvant chemotherapy (NCT) (45% and 90% respectively). This phase II study was carried out to evaluate the efficacy and toxicity of a regimen . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.